NCT06806735

Brief Summary

Measuring the volumes of hypertrophic scars and keloids, two specific kind of scars, over different points in time in patients who have undergone surgery and evaluate 3D-cameras as a possible measuring and documenting tool including volumetry.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2025

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 21, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 4, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

9 months

First QC Date

January 21, 2025

Last Update Submit

February 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Measurability

    The objective of this study is to determine the feasibility of utilizing 3D cameras to accurately measure hypertrophic scars and keloids. The primary outcome of this study is the measurement of the volumes of hypertrophic scars in cubic millimeters (equivalent to milliliters) over a period of one year. This will allow for an evaluation of the accuracy of 3D photography and for the observation of any potential changes.

    Day 0, Month 3, 6 and 12

Interventions

3D-Pictures will be taken of hypertrophic scars and keloids to document them.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with hypertrophic scars or keloids of the University Hospital Zurich

You may qualify if:

  • All patients with hypertrophic scars or keloids, written consent to participate in the study, minimum age of 18 years.

You may not qualify if:

  • Absence of written consent, unwillingness to contribute data, inability to understand the study protocol.
  • lack of hypertrophic scars or keloid

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsspital Zürich

Zurich, Canton of Zurich, 8091, Switzerland

RECRUITING

MeSH Terms

Conditions

Cicatrix, HypertrophicKeloid

Condition Hierarchy (Ancestors)

CicatrixFibrosisPathologic ProcessesPathological Conditions, Signs and SymptomsCollagen DiseasesConnective Tissue DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Prof. Dr. med. Soyka

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 21, 2025

First Posted

February 4, 2025

Study Start

January 10, 2025

Primary Completion

September 30, 2025

Study Completion

September 30, 2025

Last Updated

February 7, 2025

Record last verified: 2025-02

Locations